Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Investigator is leaving the university
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Institute of Clinical and Translational Sciences | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The investigators propose a pilot study of monitoring a sample of 6 older patients receiving active cancer treatment over a period of 6 months with in-home sensor monitors installed and maintained by Foresite Healthcare. The investigators also propose exploring the beliefs and attitudes of those who are not willing to allow in-home sensor monitoring by asking them to complete a brief survey related to in-home sensor monitoring. The investigators hypothesize that patients will find the equipment acceptable and unintrusive, that changes in home-monitored patient parameters will precede clinical events and that patient trajectories will be more fully characterized with the in home sensors.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm A: In-Home Sensor Monitoring | Experimental | Older adults with cancer undergoing systemic cancer treatment will undergo passive monitoring with motion sensors and bed sensor. Passive infrared (PIR) motion sensors will be installed in their homes to detect presence in a particular room (e.g., bathroom or kitchen) as well as for specific activities. There will also be a bed sensor, which is a pneumatic strip installed under the bed linens, which measures displacement of the resident's upper torso as he or she lies on the bed. Participants will complete a baseline primarily self-administered survey, an abbreviated assessment with each follow up clinic visit (at least once per month) for 6 months of follow up and a final end of study assessment. |
|
| Arm B: Survey Only | No Intervention | Patients that choose to not proceed with in-home sensor monitoring will be asked to complete a brief survey that explores attitudes regarding in-home sensor monitoring |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| In-home sensor monitoring | Other | -Installed and maintained by Foresite Healthcare |
|
| Measure | Description | Time Frame |
|---|---|---|
| Acceptability of in-home sensor monitoring as measured by a modified version of the Intelligent Systems for Assessment of Aging Technology Survey (Arm A only) |
| 6 months |
| Heart rate (Arm A only) | -A meaningful change is heart rate outside the normal range of 60-100 | 6 months |
| Changes in gait speed of .1m/s or more (Arm A only) | 6 months | |
| Stride length (Arm A only) | 6 months | |
| Number of Falls (Arm A only) | 6 months | |
| Number of Hospitalizations (Arm A only) | 6 months | |
| Number of Emergency room visits (Arm A only) | 6 months | |
| Number of Infections requiring medical intervention (e.g. oral antibiotics) (Arm A only) |
Not provided
Not provided
Inclusion Criteria:
Arm A:
Arm B:
Exclusion Criteria:
Arm A:
Arm B:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tanya M Wildes, M.D., MSCI | Washington University School of Medicine | Principal Investigator |
Not provided
Not provided
| Label | URL |
|---|---|
| Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| Number of grade ≥3 adverse events measured by CTCAE (Arm A only) | 6 months |
| Patient reported outcomes of 10 common symptoms (Arm A) |
| 6 months |
| Reason for not choosing in-home monitoring as measured by a modified version of the Intelligent Systems for Assessment of Aging Changes Technology Survey (Arm B only) |
| At the time of invitation to participate in the study (Day 1) |